메뉴 건너뛰기




Volumn 878, Issue 15-16, 2010, Pages 1085-1092

Validation of a quantitative assay for human neutrophil peptide-1, -2, and -3 in human plasma and serum by liquid chromatography coupled to tandem mass spectrometry

Author keywords

Human neutrophil peptides; LC MS MS; Quantification

Indexed keywords

ANTIMICROBIAL PEPTIDE; AVERAGE CONCENTRATION; CHARGED IONS; CHROMATOGRAPHIC SEPARATIONS; DEFENSINS; ENDOGENOUS CONCENTRATION; FRAGMENTATION EFFICIENCY; HUMAN NEUTROPHIL; HUMAN NEUTROPHIL PEPTIDES; HUMAN PLASMAS; INTENSIVE-CARE PATIENTS; INTER-ASSAY PRECISION; INTERNAL STANDARDS; LC-MS/MS; LIMIT OF DETECTION; LIQUID CHROMATOGRAPHY COUPLED TO TANDEM MASS SPECTROMETRY; LIQUID CHROMATOGRAPHY-TANDEM MASS SPECTROMETRY; LOWER LIMIT OF QUANTIFICATIONS; MULTIPLE REACTION MONITORING; QUANTITATIVE ASSAY; SERUM SAMPLES; SIMULTANEOUS MEASUREMENT; TANDEM MASS SPECTROMETRIC DETECTION; TRIPLE-QUADRUPOLE MASS SPECTROMETER; WATER-METHANOL;

EID: 77951094005     PISSN: 15700232     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jchromb.2010.03.014     Document Type: Article
Times cited : (14)

References (29)
  • 26
    • 77951092654 scopus 로고    scopus 로고
    • Guidance for industry: Bioanalytical Method Validation, U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CEDR), Center for Veterinary Medicine (CVM), BP, May 2001. http://www.fda.gov/cder/guidance/4252fnl.htm.
    • Guidance for industry: Bioanalytical Method Validation, U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CEDR), Center for Veterinary Medicine (CVM), BP, May 2001. http://www.fda.gov/cder/guidance/4252fnl.htm.


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.